Patient info Open main menu

ASDA FLU-MAX ALL-IN-ONE CHESTY COUGH & COLD TABLETS, NUMARK FLU ALL-IN-ONE CHESTY COUGH & COLD TABLETS, GALPHARM FLU-MAX ALL-IN-ONE CHESTY COUGH & COLD TABLETS, NUMARK MUCUS COUGH & COLD RELIEF ALL-IN-ONE TABLETS, MORRISONS COLD & FLU RELIEF ALL IN ONE - patient leaflet, side effects, dosage

Dostupné balení:

Patient leaflet - ASDA FLU-MAX ALL-IN-ONE CHESTY COUGH & COLD TABLETS, NUMARK FLU ALL-IN-ONE CHESTY COUGH & COLD TABLETS, GALPHARM FLU-MAX ALL-IN-ONE CHESTY COUGH & COLD TABLETS, NUMARK MUCUS COUGH & COLD RELIEF ALL-IN-ONE TABLETS, MORRISONS COLD & FLU RELIEF ALL IN ONE

3. how to take this medicine

Swallow the tablets whole with water.

Do not chew.

Adults, the elderly and children 12 years and over: 2 tablets every 4 hours, as required. Do not take more than 8 tablets (4 doses) in any 24 hour period.

Do not give to children under 12 years. Do not take more medicine than the label tells you to. If you do not get better, talk to your doctor.

Talk to a doctor at once if you take too much of this medicine even if you feel well. This is because too much paracetamol can cause delayed, serious liver damage. Go to your nearest hospital casualty department. Take your medicine and this leaflet with you.

4.possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking this medicine and tell your doctor immediately if you experience:

  • Allergic reactions with swelling of the mouth, lips, tongue, throat or face which may make it difficult to breathe (anaphylaxis, angioedema)
  • Severe skin reactions can include ulcers, blistering or peeling of the skin (Steven-Johnsons syndrome or toxic epidermal necrolysis)
  • Breathing problems and wheezing. These are more likely if you have experienced them before when taking other painkillers such as ibuprofen or aspirin
  • Unexplained bruising or bleeding (caused by low platelets in the blood)
  • Recurring fevers or infections (caused by low white blood cells which increases the likelihood of infections)
  • Severe stomach discomfort (caused by inflammation of the pancreas)
  • Liver problems, which may appear as jaundice (yellowing of the eyes and skin), nausea and abdominal pain (hepatic dysfunction)
  • Unusually fast pulse rate or a sensation of an unusually fast or irregular heartbeat (tachycardia, palpitations).

The following side effects may also occur. Tell your doctor if you get them.

  • Difficulty passing water (the frequency is unknown but is more likely to occur in men with an enlarged prostate)
  • Less serious allergic reaction including rashes, dermatitis or urticaria (hives)
  • Headache, dizziness, insomnia (problems sleeping)
  • Nausea (feeling sick), vomiting, stomach discomfort, diarrhoea
  • Nervousness, irritability, restlessness, excitability
  • Increased blood pressure.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

5. how to store your medicine keep out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister foil. The expiry date refers to the last day of the month. Do not store above 25°C.

  • 6. What is in this medicine?

Each white, capsule-shaped tablet contains the active ingredients: paracetamol 250 mg, guaifenesin 100 mg and phenylephrine hydrochloride 5 mg.

The other ingredients are: microcrystalline cellulose, stearic acid, povidone, hypromellose and polyethylene glycol.

This product is available in a pack size of 16 tablets.

  • 7. Who makes this medicine? Manufactured for The Boots Company PLC, Nottingham, NG2 3AA by the Marketing Authorisation holder Wrafton Laboratories Limited, Braunton, Devon, EX33 2DL, UK. Text revised: January 2020.